Royalty Pharma plc (RPRX)
USD 31.71
(1.6%)
USD 31.71
(1.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.13 Billion USD | 0.27% |
| 2022 | 6.11 Billion USD | -13.77% |
| 2021 | 7.09 Billion USD | 22.0% |
| 2020 | 5.81 Billion USD | -2.34% |
| 2019 | 5.95 Billion USD | -4.52% |
| 2018 | 6.23 Billion USD | -4.34% |
| 2017 | 6.52 Billion USD | 13.91% |
| 2016 | 5.72 Billion USD | -1.37% |
| 2015 | 5.8 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.6 Billion USD | 23.82% |
| 2024 Q1 | 6.13 Billion USD | 0.07% |
| 2023 Q4 | 6.13 Billion USD | 0.07% |
| 2023 Q2 | 6.12 Billion USD | 0.07% |
| 2023 Q3 | 6.13 Billion USD | 0.07% |
| 2023 Q1 | 6.12 Billion USD | 0.07% |
| 2023 FY | 6.13 Billion USD | 0.27% |
| 2022 Q2 | 7.1 Billion USD | 0.07% |
| 2022 FY | 6.11 Billion USD | -13.77% |
| 2022 Q4 | 6.11 Billion USD | 0.07% |
| 2022 Q1 | 7.1 Billion USD | 0.07% |
| 2022 Q3 | 6.11 Billion USD | -13.95% |
| 2021 Q2 | 5.82 Billion USD | 0.08% |
| 2021 FY | 7.09 Billion USD | 22.0% |
| 2021 Q4 | 7.09 Billion USD | 0.08% |
| 2021 Q3 | 7.09 Billion USD | 21.72% |
| 2021 Q1 | 5.82 Billion USD | 0.08% |
| 2020 Q1 | 5.77 Billion USD | -3.04% |
| 2020 FY | 5.81 Billion USD | -2.34% |
| 2020 Q4 | 5.81 Billion USD | 0.08% |
| 2020 Q3 | 5.81 Billion USD | 1.44% |
| 2020 Q2 | 5.72 Billion USD | -0.79% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 5.95 Billion USD | 0.0% |
| 2019 FY | 5.95 Billion USD | -4.52% |
| 2018 FY | 6.23 Billion USD | -4.34% |
| 2017 FY | 6.52 Billion USD | 13.91% |
| 2016 FY | 5.72 Billion USD | -1.37% |
| 2015 FY | 5.8 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 25.9 Million USD | -23581.044% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -6807503.968% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -4336.086% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -9230.239% |
| Agenus Inc. | 137.32 Million USD | -4367.744% |
| Fortress Biotech, Inc. | 60.85 Million USD | -9981.644% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -9178412.656% |
| Novavax, Inc. | 168.01 Million USD | -3551.608% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -45552.839% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -27887559.091% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -23260.945% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -10071.06% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -8517.457% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | -161.853% |
| AlloVir, Inc. | 16.64 Million USD | -36752.985% |
| Aptorum Group Limited | 3.05 Million USD | -200497.842% |
| Ardelyx, Inc. | 51.54 Million USD | -11802.312% |
| Bicycle Therapeutics plc | 40.08 Million USD | -15207.597% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -5998.814% |
| Chimerix, Inc. | 125 Thousand USD | -4908128.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -189340.693% |
| CRISPR Therapeutics AG | 223 Million USD | -2651.163% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -14511.996% |
| Precision BioSciences, Inc. | 7.72 Million USD | -79341.732% |
| Dyadic International, Inc. | 88.87 Thousand USD | -6903562.653% |
| Elevation Oncology, Inc. | 30.13 Million USD | -20257.982% |
| Fortress Biotech, Inc. | 60.85 Million USD | -9981.644% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | -2032.306% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Innoviva, Inc. | 446.23 Million USD | -1274.903% |
| IO Biotech, Inc. | 1.83 Million USD | -333520.718% |
| Jaguar Health, Inc. | 30.99 Million USD | -19695.712% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -106507.906% |
| ContextLogic Inc. | 6 Million USD | -102154.75% |
| AbCellera Biologics Inc. | 71.22 Million USD | -8514.312% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -9976622.063% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -5765.025% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -5212.855% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -54723.385% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -6345.372% |
| NextCure, Inc. | 5.94 Million USD | -103031.367% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -161312.391% |
| ChromaDex Corporation | 2.57 Million USD | -238163.495% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -545258.667% |
| Incyte Corporation | 29.16 Million USD | -20938.629% |
| Opthea Limited | 200.53 Million USD | -2959.447% |
| MiMedx Group, Inc. | 48.09 Million USD | -12655.535% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -736428.812% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -27647.66% |
| PDS Biotechnology Corporation | 19.5 Million USD | -31353.027% |
| Pharming Group N.V. | 166.1 Million USD | -3593.618% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -5161804.642% |
| Acelyrin, Inc. | 1.19 Million USD | -513742.965% |
| PureTech Health plc | 18.25 Million USD | -33518.0% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -30425.325% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -98649.155% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -16022686.033% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -11551.193% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -23529.968% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -18206.087% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -1333657.609% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -508630.1% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | 103.29 Million USD | -5839.863% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -162682.834% |
| Senti Biosciences, Inc. | 33.53 Million USD | -18193.533% |
| ImmuCell Corporation | 10.54 Million USD | -58106.796% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -17654.616% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -26546.189% |
| Precigen, Inc. | 5.89 Million USD | -103976.081% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -4231131.034% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -128441.483% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -3113.335% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -5780.202% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -14210.036% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -390682.484% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -6197157.576% |
| Windtree Therapeutics, Inc. | 15 Million USD | -40801.9% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -24050.862% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -6201.649% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -838053.689% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -2864.364% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -192349.341% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -590967.919% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -27380.449% |
| Aptose Biosciences Inc. | 621 Thousand USD | -987868.599% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -606792.735% |
| Century Therapeutics, Inc. | 46.65 Million USD | -13049.481% |
| Kura Oncology, Inc. | 9.33 Million USD | -65644.589% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -22878.596% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -4445758.696% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -65273.308% |
| Autolus Therapeutics plc | 47.91 Million USD | -12704.786% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -124956.767% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -90484.453% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -4595.611% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -75597.532% |
| IGM Biosciences, Inc. | 34.67 Million USD | -17595.215% |
| INmune Bio, Inc. | 397 Thousand USD | -1545311.839% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -3431.038% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -151229.342% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -4175011.773% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -12226.78% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -11142.963% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -13327.188% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -1196.089% |
| Verastem, Inc. | 40.08 Million USD | -15205.306% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -139274.943% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -60923.324% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -93411.431% |
| Histogen Inc. | 4.38 Million USD | -139847.194% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -695510.544% |
| Organovo Holdings, Inc. | 888 Thousand USD | -690810.473% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -20350.95% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -146187.196% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -32370.415% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -8004.736% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -6589611.505% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -23581.959% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -2297759.551% |
| Amarin Corporation plc | 8.73 Million USD | -70121.872% |
| Mesoblast Limited | 100.48 Million USD | -6005.794% |
| Turnstone Biologics Corp. | 1.18 Million USD | -515903.785% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -7732.712% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -5628601.835% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -7381.234% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -3130.049% |
| Better Therapeutics, Inc. | 10.34 Million USD | -59189.573% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -26430.962% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -6494.741% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -474767.26% |
| Gritstone bio, Inc. | 40.14 Million USD | -15183.193% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -338118.578% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -3894.508% |
| Insmed Incorporated | 1.19 Billion USD | -414.122% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -96518.661% |
| OmniAb, Inc. | 22.07 Million USD | -27692.911% |
| Alector, Inc. | 30.45 Million USD | -20044.75% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -5941.997% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -76143.134% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -1338.199% |
| Aura Biosciences, Inc. | 16.87 Million USD | -36268.02% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -10683.712% |
| Immunic, Inc. | 639 Thousand USD | -960038.498% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -20475.086% |
| Veracyte, Inc. | 7.52 Million USD | -81432.027% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -851.406% |
| FibroGen, Inc. | 89.69 Million USD | -6740.011% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -141363.8% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -4688226.723% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | -20.112% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -16581751.351% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -309762.879% |
| TG Therapeutics, Inc. | 100.11 Million USD | -6028.054% |
| Galecto, Inc. | 66 Thousand USD | -9295786.364% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -4511138.971% |
| Fortrea Holdings Inc. | 1.63 Billion USD | -275.844% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -101899.751% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -113579.544% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -338118.578% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -28506.728% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -16683.709% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -1186608.897% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -13462.837% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -19967.001% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -13594.221% |
| Vaxxinity, Inc. | 13.26 Million USD | -46162.14% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -656.262% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -1366171.91% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -69706.406% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | -126.989% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -1941445.886% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -137524.159% |
| Ainos, Inc. | 5.92 Million USD | -103509.338% |
| Pluri Inc. | 29.05 Million USD | -21017.561% |
| Prothena Corporation plc | 10.72 Million USD | -57126.798% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -30806.68% |
| Celularity Inc. | 26.17 Million USD | -23337.693% |
| Rallybio Corporation | 173 Thousand USD | -3546307.514% |
| Cue Biopharma, Inc. | 4.2 Million USD | -145908.686% |
| MeiraGTx Holdings plc | 72.11 Million USD | -8407.169% |
| Omeros Corporation | 329.7 Million USD | -1760.841% |
| Humacyte, Inc. | 38.6 Million USD | -15794.521% |
| Immunocore Holdings plc | 82.64 Million USD | -7323.751% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -380264.848% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -171420.408% |
| Blueprint Medicines Corporation | 610.96 Million USD | -904.201% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -420701.44% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -12502.262% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -6649.414% |
| Pulmatrix, Inc. | 8.32 Million USD | -73579.416% |
| Elicio Therapeutics, Inc. | 6 Million USD | -102035.592% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -47295.017% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -6241.576% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -1308063.113% |
| Cytokinetics, Incorporated | 607.37 Million USD | -910.135% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -70485.423% |
| Nutriband Inc. | 79.82 Thousand USD | -7685722.915% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -136726.16% |
| Vor Biopharma Inc. | 31.83 Million USD | -19175.165% |
| Roivant Sciences Ltd. | 477.85 Million USD | -1183.919% |
| Evogene Ltd. | 10.65 Million USD | -57492.087% |
| ProKidney Corp. | 3.61 Million USD | -169852.493% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -808237.945% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -23304940.644% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | -253.474% |
| CorMedix Inc. | 517.01 Thousand USD | -1186579.058% |
| BioLineRx Ltd. | 6.62 Million USD | -92466.159% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -16554.772% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -8451.993% |
| Atai Life Sciences N.V. | 15.21 Million USD | -40234.528% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -728219.696% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -2405894.118% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -14118.505% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -1493905.99% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -448058.145% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -925144.194% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -3345.434% |
| Biomea Fusion, Inc. | 7.83 Million USD | -78256.13% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -2058.693% |
| Mereo BioPharma Group plc | 5.3 Million USD | -115660.094% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -285262.093% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -1043315.816% |
| Absci Corporation | 4.66 Million USD | -131558.476% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -53148.438% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -26933.642% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -61222.189% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -53227.119% |
| Allakos Inc. | 38.21 Million USD | -15954.651% |
| Imunon, Inc. | 1.13 Million USD | -538416.87% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -71000.765% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -733785.766% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -61352750.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -6844.61% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -130188.49% |
| XOMA Corporation | 118.51 Million USD | -5076.669% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -60832.416% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -16446.522% |
| aTyr Pharma, Inc. | 13.76 Million USD | -44465.156% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -77571.667% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -24476.53% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -30265.182% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -40901800.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -2205329.742% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -42344.45% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -309.224% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -4505407.7% |
| UroGen Pharma Ltd. | 98.55 Million USD | -6125.492% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -4014.493% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -32077.506% |
| Entera Bio Ltd. | 256 Thousand USD | -2396495.703% |
| GH Research PLC | 631 Thousand USD | -972211.41% |
| Lisata Therapeutics, Inc. | 137.00 USD | -4478310118.978% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -955551.869% |
| Xencor, Inc. | 14.64 Million USD | -41801.96% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -4083257.182% |
| Replimune Group, Inc. | 71.99 Million USD | -8422.413% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -4090090.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -87471.867% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -4505407.7% |
| Portage Biotech Inc. | 7000.00 USD | -87646828.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -925144.194% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -429241.148% |
| OncoCyte Corporation | 2.2 Million USD | -278270.463% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -9170044.234% |
| Purple Biotech Ltd. | 163 Thousand USD | -3763878.528% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -241923.077% |
| scPharmaceuticals Inc. | 38.81 Million USD | -15708.109% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -24203.934% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -8404400.0% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -331000.108% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -23185.581% |
| Curis, Inc. | 1.48 Million USD | -411940.631% |
| Daré Bioscience, Inc. | 3.91 Million USD | -156665.276% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -879239.702% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -102254650.0% |
| BeiGene, Ltd. | 197.61 Million USD | -3004.619% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -672997.641% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -7514.378% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -11723.864% |
| bluebird bio, Inc. | 224.41 Million USD | -2633.853% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -934.452% |
| DBV Technologies S.A. | 4.52 Million USD | -135456.452% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -457757.09% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -62877.674% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -162769.259% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -1526.262% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -14209.035% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -357225.859% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -661029.849% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -35025.007% |
| MacroGenics, Inc. | 30.19 Million USD | -20218.204% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -34556.753% |
| Prime Medicine, Inc. | 4.35 Million USD | -140714.437% |
| Aditxt, Inc. | 1.04 Million USD | -588843.637% |
| Adagene Inc. | 13.54 Million USD | -45212.183% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -44562.481% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -1082.804% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -35793.553% |
| SciSparc Ltd. | 24 Thousand USD | -25563587.5% |
| Vericel Corporation | 81.85 Million USD | -7395.217% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -7380.52% |
| Generation Bio Co. | 89.77 Million USD | -6734.145% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -27555.105% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -2940.295% |
| Invivyd, Inc. | 722 Thousand USD | -849662.465% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -12549.551% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -209844345.281% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -160299.608% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -26675052.174% |
| 2seventy bio, Inc. | 244.01 Million USD | -2414.327% |
| ADMA Biologics, Inc. | 130.59 Million USD | -4597.984% |
| Clene Inc. | 7.15 Million USD | -85684.186% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -181618.435% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -2377.732% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -557146.594% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -2333906.049% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -3085.175% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -21500.834% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -63550.638% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -5393.973% |
| Evaxion Biotech A/S | 8.48 Million USD | -72175.491% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -8088.569% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -9380.468% |
| Trevena, Inc. | 35.23 Million USD | -17313.462% |
| Surrozen, Inc. | 882 Thousand USD | -695510.544% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -98601.496% |
| Cingulate Inc. | 135.09 Thousand USD | -4541225.25% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -25964.34% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -12735.324% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -3408391.667% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -24074.652% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -35085.439% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -655379.167% |
| Statera Biopharma, Inc. | 11.43 Million USD | -53571.681% |
| ImmunityBio, Inc. | 836.95 Million USD | -633.051% |
| Korro Bio, Inc. | 31.21 Million USD | -19554.296% |
| Kineta, Inc. | 150 Thousand USD | -4090090.0% |
| BioVie Inc. | 349.89 Thousand USD | -1753369.622% |
| Codexis, Inc. | 12.24 Million USD | -50012.595% |
| Celularity Inc. | 26.17 Million USD | -23337.693% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -12801.451% |
| Celcuity Inc. | 37.03 Million USD | -16465.997% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -3479037.486% |
| Cibus, Inc. | 17.67 Million USD | -34613.619% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -181471.027% |
| Kodiak Sciences Inc. | 100 Million USD | -6035.285% |
| Annexon, Inc. | 29.19 Million USD | -20918.448% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -9393.377% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -546716.845% |
| Avalo Therapeutics, Inc. | 2 Million USD | -306664.25% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | -338.117% |
| Eyenovia, Inc. | 8.95 Million USD | -68395.331% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -9244.165% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -75253.537% |
| Arcellx, Inc. | 50.84 Million USD | -11967.593% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -420701.44% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -28788.243% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -581443.602% |
| Moolec Science SA | 99.04 Thousand USD | -6194279.379% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -22112.393% |
| Geron Corporation | 35.05 Million USD | -17403.88% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -1038019.289% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -373547.077% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -19328502.483% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -26404.601% |
| Humacyte, Inc. | 38.6 Million USD | -15794.521% |
| Structure Therapeutics Inc. | 4.01 Million USD | -152785.248% |
| 89bio, Inc. | 24.79 Million USD | -24644.041% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -49242.81% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -328693.408% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -594404.36% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -6065.62% |
| Notable Labs, Ltd. | 1.52 Million USD | -401950.131% |
| Liquidia Corporation | 2.36 Million USD | -259429.822% |
| Mustang Bio, Inc. | 1.97 Million USD | -310076.188% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -44562.481% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -88139.393% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -1935321.136% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -12200.83% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -63782.601% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -9368320.651% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -4511138.971% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -97845.163% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -4719350.0% |
| PepGen Inc. | 17.1 Million USD | -35778.86% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -1294263.924% |
| United Therapeutics Corporation | 300 Million USD | -1945.095% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -25526.686% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -147281.771% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -1061367.993% |
| XOMA Corporation | 118.51 Million USD | -5076.669% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -16581751.351% |
| Bionomics Limited | 117.62 Million USD | -5115.837% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -657486.817% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -109263.369% |
| uniQure N.V. | 130.06 Million USD | -4617.091% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -10371.557% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -894256.414% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -141363.8% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -442880.866% |
| Altimmune, Inc. | 175 Thousand USD | -3505777.143% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -1481.838% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -109263.369% |
| Compugen Ltd. | 719 Thousand USD | -853208.067% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -121007.086% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -7155.969% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -61685.347% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -96079.417% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -6611.831% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -61685.347% |
| Instil Bio, Inc. | 81.42 Million USD | -7434.706% |
| argenx SE | 15.35 Million USD | -39858.871% |
| Immunome, Inc. | 1.34 Million USD | -457757.09% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -1144542.724% |
| Verona Pharma plc | 48.37 Million USD | -12583.022% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -66472.103% |
| Shattuck Labs, Inc. | 3.4 Million USD | -180031.679% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -7217882.353% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -3651855.357% |
| Moolec Science SA | 99.04 Thousand USD | -6194279.379% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -55513.201% |
| AnaptysBio, Inc. | 16.03 Million USD | -38157.062% |
| Design Therapeutics, Inc. | 2.33 Million USD | -262765.681% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -22663580.692% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -102154.75% |
| Achilles Therapeutics plc | 1.07 Million USD | -570093.773% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -66472.103% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -30774804.695% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -36545.124% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -7685722.915% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -82231303.297% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -47194400.0% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -1691.418% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -24958.344% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -245312.382% |
| Palisade Bio, Inc. | 90 Thousand USD | -6816883.333% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -3162418.041% |
| Beam Therapeutics Inc. | 159.91 Million USD | -3736.687% |
| Neurogene Inc. | 13.37 Million USD | -45778.15% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -1902.24% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -10255800.839% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -613428.5% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -15045.86% |
| Athira Pharma, Inc. | 1.21 Million USD | -504031.882% |
| Vaccinex, Inc. | 26 Thousand USD | -23597150.0% |
| HCW Biologics Inc. | 6.3 Million USD | -97218.774% |
| XOMA Corporation | 118.51 Million USD | -5076.669% |
| Nektar Therapeutics | 112.62 Million USD | -5347.534% |
| Arvinas, Inc. | 800 Thousand USD | -766810.625% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -42344.45% |
| Merus N.V. | 10.48 Million USD | -58398.141% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -41117.904% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -45586.834% |
| Rezolute, Inc. | 1.66 Million USD | -369495.482% |
| Clene Inc. | 7.15 Million USD | -85684.186% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -8364524.802% |
| BeyondSpring Inc. | 3.36 Million USD | -182280.648% |
| Synlogic, Inc. | 12.49 Million USD | -49017.645% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -18687.619% |
| Krystal Biotech, Inc. | 6.62 Million USD | -92578.021% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -3489.586% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -102222.965% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -12951463.193% |
| MannKind Corporation | 252.15 Million USD | -2333.179% |
| Ikena Oncology, Inc. | 7.18 Million USD | -85349.652% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -3082957.789% |
| Gossamer Bio, Inc. | 197.4 Million USD | -3007.968% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -1179762.5% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -2080.83% |
| Mural Oncology plc | 8.91 Million USD | -68750.69% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -13927.998% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -427148.259% |
| Champions Oncology, Inc. | 6.09 Million USD | -100593.993% |
| REGENXBIO Inc. | 82.22 Million USD | -7361.853% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -1241852.984% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -138269.08% |
| Vaxart, Inc. | 2.62 Million USD | -233803.355% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -2258583.655% |
| Cellectis S.A. | 36.24 Million USD | -16829.127% |
| Longeveron Inc. | 1.44 Million USD | -423607.528% |
| Repare Therapeutics Inc. | 1.01 Million USD | -607353.96% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -441.74% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -13604.315% |
| Revolution Medicines, Inc. | 80.57 Million USD | -7514.378% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -191149.532% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -3466162.712% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -4987936.585% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -746.597% |
| Denali Therapeutics Inc. | 44.98 Million USD | -13539.726% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -48965.598% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -4541225.25% |
| Passage Bio, Inc. | 22.92 Million USD | -26667.091% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -101494.386% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -948166.615% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -30325.415% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -1251998.98% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -1505650.3% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -516338.131% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -1316484.764% |
| OmniAb, Inc. | 22.07 Million USD | -27692.911% |
| Anew Medical, Inc. | 1.54 Million USD | -398295.13% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -20655.373% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -67820.79% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -19633.95% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -151229.342% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -11800.004% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -96260.688% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -43323.349% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -912888.839% |
| Alumis Inc. Common Stock | 30.86 Million USD | -19781.027% |
| Equillium, Inc. | 384 Thousand USD | -1597630.469% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -99514.954% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -3961.785% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -12451.986% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -5099802.745% |
| Dominari Holdings Inc. | 3.02 Million USD | -202518.395% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -31028499.606% |
| vTv Therapeutics Inc. | 169 Thousand USD | -3630246.154% |
| Bio-Techne Corporation | 319 Million USD | -1823.287% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -10665.924% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -3335.864% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -39721.412% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -49446.031% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -127532.307% |
| Nkarta, Inc. | 82.27 Million USD | -7357.5% |
| BioCardia, Inc. | 982 Thousand USD | -624674.44% |
| Iterum Therapeutics plc | 18.95 Million USD | -32265.926% |